gemcitabine 38mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - gemcitabine - concentrate for solution for infusion - gemcitabine 38 mg - antineoplastic agents
gemcitabine 38 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - gemcitabine - concentrate for solution for infusion - gemcitabine 38 mg - antineoplastic agents
gemcitabine 38 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - gemcitabine - concentrate for solution for infusion - gemcitabine 38 mg - antineoplastic agents
gemcitabine 38mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - gemcitabine hydrochloride - concentrate for solution for infusion - 38 milligram(s)/millilitre - pyrimidine analogues; gemcitabine
bendamustine hcl
fresenius kabi oncology plc - bendamustine hydrochloride - pdr/conc/soln for infus - 25 milligram - bendamustine
bendamustine hcl
fresenius kabi oncology plc - bendamustine hydrochloride - pdr/conc/soln for infus - 100 milligram - bendamustine
bendamustine pdr/conc/soln for infus 2.5mg/ml (25mg vial)
fresenius kabi oncology plc - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
bendamustine pdr/conc/soln for infus 2.5mg/ml (100mg vial
fresenius kabi oncology plc - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
carboplatin 10 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - carboplatin - concentrate for solution for infusion - 10 milligram(s)/millilitre - platinum compounds; carboplatin
cisplatin 1 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - cisplatin - concentrate for solution for infusion - 1 milligram(s)/millilitre - platinum compounds; cisplatin